Belpointe Asset Management LLC Organon & Co. Transaction History

Belpointe Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$21.42 - $32.08 $1,863 - $2,790	87 Added 8.71%	1,086 $25,000
Q4 2022 Feb 08, 2023	BUY	$23.31 - $28.61 $23,286 - $28,581	999 New	999 $27,000
Q2 2022 Aug 02, 2022	SELL	$31.66 - $38.9 $9,814 - $12,059	-310 Reduced 3.8%	7,852 $265,000
Q1 2022 Apr 28, 2022	SELL	$30.45 - $39.36 $3,897 - $5,038	-128 Reduced 1.54%	8,162 $285,000
Q4 2021 Feb 15, 2022	BUY	$28.67 - $37.13 $19,380 - $25,099	676 Added 8.88%	8,290 $254,000
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $217,988 - $271,362	7,614 New	7,614 $250,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.